A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : uPAR

Search Conditions:
Search Keyword : uPAR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: uPAR
Appearance Frequency: 1518 time(s)
Long forms: 35

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
urokinase-type plasminogen activator receptor
(808 times)
Neoplasms
(188 times)
uPA (152 times)
PAI-1 (53 times)
suPAR (27 times)
1990 Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.
uPA receptor
(296 times)
Neoplasms
(84 times)
uPA (253 times)
PAI-1 (68 times)
tPA (40 times)
1989 Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
urokinase receptor
(263 times)
Biochemistry
(43 times)
uPA (40 times)
PAI-1 (18 times)
VN (12 times)
1992 Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
urokinase-type plasminogen activator
(44 times)
Biochemistry
(8 times)
uPA (9 times)
GPI (3 times)
PNH (3 times)
1992 Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
urokinase plasminogen activator
(32 times)
Allergy and Immunology
(6 times)
uPA (6 times)
PAI-1 (5 times)
suPAR (5 times)
1990 Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
uPA and its receptor
(31 times)
Neoplasms
(9 times)
uPA (23 times)
PAI-1 (5 times)
ECM (4 times)
1995 The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.
uPA, the cell surface receptor
(7 times)
Neoplasms
(4 times)
uPA (4 times)
ECM (2 times)
ATF (1 time)
1996 Regulation and role of urokinase plasminogen activator in vascular remodelling.
up-regulation of urokinase receptor
(3 times)
Medicine
(1 time)
GPI (1 time)
HPV (1 time)
PIG-U (1 time)
1996 Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of Mac-1(CD11b/CD18) and urokinase receptor (CD87).
uPA is bound to its receptor
(3 times)
Gastroenterology
(1 time)
uPA (2 times)
CKD (1 time)
FN (1 time)
2003 Aspirin inhibits highly invasive prostate cancer cells.
10  uPA, its specific cell surface receptor
(2 times)
Neoplasms
(1 time)
uPA (2 times)
ELISA (1 time)
NSCLC (1 time)
1997 Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients.
11  uPA, tPA, urokinase receptor
(2 times)
Ophthalmology
(1 time)
PAI-1 (2 times)
tPA (2 times)
uPA (1 time)
2004 Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
12  uPA-specific receptors
(2 times)
Gastroenterology
(1 time)
FBS (1 time)
PAI (1 time)
PAs (1 time)
1994 Chromosomal localization of the human urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 genes: implications in colorectal cancer.
13  urokinase and its receptor
(2 times)
Ophthalmology
(1 time)
CNV (1 time)
uPA (1 time)
2006 Role of urokinase inhibitors in choroidal neovascularization.
14  urokinase cellular receptor
(2 times)
Neurology
(1 time)
HGF (1 time)
PAs (1 time)
PNS (1 time)
1996 Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia.
15  anti-uPA receptor
(1 time)
Nephrology
(1 time)
PAI-1 (1 time)
uPA (1 time)
2015 Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated beta1-integrin endocytosis.
16  LB6-uPAR, transfected with the human urokinase receptor
(1 time)
Cell Biology
(1 time)
CK18 (1 time)
uPA (1 time)
1994 Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
17  pro-uPA associate with uPA receptor
(1 time)
Clinical Laboratory Techniques
(1 time)
EIA (1 time)
ELISA (1 time)
ER (1 time)
2012 Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.
18  pro-uPA binds to its glycosylphosphatidylinositol-anchored specific cell receptor
(1 time)
Biochemistry
(1 time)
gp330 (1 time)
uPA (1 time)
1995 Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
19  up-regulates the cell surface expression of its own receptor
(1 time)
Biochemistry
(1 time)
uPA (1 time)
2001 Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
20  uPA and its amino-terminal fragment, bound to the urokinase receptor
(1 time)
Biochemistry
(1 time)
alpha 2M (1 time)
alpha 2MRAP (1 time)
LRP (1 time)
1992 Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
21  uPA and its binding to its receptor
(1 time)
Drug Therapy
(1 time)
CNS (1 time)
PA (1 time)
tPA (1 time)
2018 The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain.
22  uPA enzyme is captured by its receptor
(1 time)
Allergy and Immunology
(1 time)
--- 2002 Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion.
23  uPA exerts its action by binding to a membrane-bound receptor
(1 time)
Neoplasms
(1 time)
PAI (1 time)
TCC-UUT (1 time)
uPA (1 time)
1998 Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma.
24  uPA mediates its action while attached to a membrane-bound receptor
(1 time)
Neoplasms
(1 time)
tPA (1 time)
uPA (1 time)
1995 Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.
25  uPA to its specific surface receptor
(1 time)
Pharmacology
(1 time)
--- 2011 The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling.
26  uPA, its cognate receptor
(1 time)
Antineoplastic Agents
(1 time)
BM (1 time)
ECM (1 time)
PAI-1 (1 time)
2009 The urokinase plasminogen activator system: a target for anti-cancer therapy.
27  uPA, one of the fibrinolytic enzymes, its receptor
(1 time)
Pulmonary Medicine
(1 time)
SP-A (1 time)
2004 Preservation of the characteristics of the cultured human type II alveolar epithelial cells.
28  uPA-system, the urokinase receptor
(1 time)
Cardiology
(1 time)
PAI-1 (1 time)
VEGF (1 time)
VEGFR2 (1 time)
2004 Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
29  uPAR and PAI-1 levels were studied by ELISA, RT-PCR
(1 time)
Rheumatology
(1 time)
RA (1 time)
2005 Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
30  uPAR knockout
(1 time)
Cardiology
(1 time)
GLUT2 (1 time)
2011 The absence of urokinase-type plasminogen activator receptor plays a role in the insulin-independent glucose metabolism.
31  upon activation and binding to its receptor
(1 time)
Neoplasms
(1 time)
ISH (1 time)
TCC (1 time)
uPA (1 time)
2004 In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
32  urokinase plasminogen activator receptor inflammatory biomarker
(1 time)
Nanotechnology
(1 time)
suPAR (1 time)
2013 Nanomechanical recognition of prognostic biomarker suPAR with DVD-ROM optical technology.
33  urokinase with its classical receptor
(1 time)
Biochemistry
(1 time)
--- 2008 Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis.
34  urokinase, allowing the fusion protein to bind to urokinase receptor
(1 time)
Nanomedicine
(1 time)
ATF (1 time)
DIP (1 time)
FA1 (1 time)
2014 A novel tumor targeting drug carrier for optical imaging and therapy.
35  urokinase-type plasminogen activator receptor concentrations
(1 time)
BC (1 time)
SELDI-TOF-MS (1 time)
2013 The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.